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Abstract
Background: Despite the growth of biomedical research in South Africa, there are few insights
into the operation of Research Ethics Committees (RECs) in this setting. We investigated the
composition, operations and training needs of health RECs in South Africa against the backdrop of
national and international guidelines.
Methods: The 12 major health RECs in South Africa were surveyed using semi-structured
questionnaires that investigated the composition and functions of each REC as well as the
operational issues facing committees.
Results: Health RECs in SA have an average of 16 members and REC members are predominantly
male and white. Overall, there was a large discrepancy in findings between under-resourced RECs
and well resourced RECs. The majority of members (56%) are scientists or clinicians who are
typically affiliated to the same institution as the health REC. Community representatives account
for only 8% of membership. Training needs for health REC members varied widely.
Conclusion: Most major health RECs in South Africa are well organized given the resource
constraints that exist in relation to research ethics in developing countries. However, the gender,
racial and occupational diversity of most of these RECs is suboptimal, and most RECs are not
constituted in accordance with South African guidelines. Variability in the operations and training
needs of RECs is a reflection of apartheid-entrenched influences in tertiary education in SA. While
legislation now exists to enforce standardization of research ethics review systems, no provision
has been made for resources or capacity development, especially to support historically-
disadvantaged institutions. Perpetuation of this legacy of apartheid represents a violation of the
principles of justice and equity.
Background
The system of ethical review in South Africa dates back to
1966 when the first REC was established at the University
of the Witwatersrand, and since then most major tertiary
institutions have developed research ethics committees.
Today there are approximately 34 local RECs in South
Africa [1], two of which are part of private, non-academic
institutions. In 2002, the Office for Human Research Pro-
tections (OHRP) visited SA and granted Federal Wide
Assurances (FWAs) to 8 RECs in the country. The FWAs
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whereby written policies and procedures were compared
to practice. This is a voluntary process and the FWA is an
endorsement of an institution's commitment to such
quality assurance. Recently, the National Health Act [2]
has made provision for the establishment of a National
Health Research Ethics Council (NHREC) whose respon-
sibility it is to set guidelines for the functioning of local
RECs, to register and audit local RECs, to set norms and
standards for research, to adjudicate complaints about the
functioning of RECs and to institute disciplinary action
against those who violate norms or guidelines for research
in terms of the Act.
In 2000, the South African Good Clinical Practice (GCP)
guideline was published by the Department of Health [3].
This national guideline specifies composition of RECs in
terms of race, gender and occupational identity. A more
recent guideline released by the Department of Health has
revised and strengthened these requirements [1]. How-
ever, there are no data to document whether RECs in SA
are constituted in accordance with these national guide-
lines.
In 2001, the World Health Organisation Regional Com-
mittee for Africa expressed concern that some health
related studies undertaken in the region were not sub-
jected to any form of ethics review [4]. While the practice
of ethical review by health RECs is firmly entrenched in
South Africa [5], the quality and consistency of ethical
review in South Africa remains unclear. There are few
insights into the capacity of RECs in South Africa. South
Africa is a popular research site for multinational collabo-
rative research[6] and hence is involved in dual review of
hundreds of research protocols annually [7]. Some of the
reasons quoted for conducting research in Africa rather
than in developed countries include lower costs, lower
risk of litigation and less stringent ethical review [8]. Con-
cerns have also been raised that RECs in developing coun-
tries may not promote high standards of research
participant protection as a result of a lack of financial and
adequately trained human resources [9]. Hence, data on
developing country RECs are of interest to researchers and
RECs around the world especially those who undertake
research in South Africa.
Given the explosion of biomedical research involving
human participants in South Africa, and the lack of
insight into research ethics review infrastructure, we
examined the composition, operations and training needs
of the major health RECs in South Africa against the back-
drop of national and international guidelines.
Methods
The RECs chosen for this survey were identified in 2003
via the chair of the Interim National Health Research Eth-
ics Committee who provided a list of 22 RECs. Of these
three were private and 19 institutional. Nine of the 19
were attached to universities: University of Cape Town,
University of Stellenbosch, University of Pretoria, Medical
University of South Africa, University of Witwatersrand,
University of Transkei, University of Kwa-Zulu Natal, Uni-
versity of Orange Free State. The ninth REC is attached to
the Medical Research Council (MRC) of South Africa. The
remaining 10 academic RECs are smaller, part-time com-
mittees attached to Technicons (vocational colleges).
These RECs were excluded from this sample due to a tran-
sition process involving mergers of various institutions in
keeping with a rationalisation process in higher educa-
tion. If a committee was involved with very little health
research, if any, it was also excluded. Where RECs were
attached to universities, only those in the Health Sciences
Faculties were included in the sample as this is where
health research is primarily reviewed.
Approval for the study was granted by the Research Com-
mittee, University of Stellenbosch. The study was con-
ducted in accordance with the Declaration of Helsinki
2000 [10]. Permission to administer the questionnaires to
administrative officers and to conduct the interviews with
chairpersons was sought telephonically from the Chair-
person of each REC. All 12 REC chairpersons agreed to
participate and appointments were secured at the various
institutions. Chairpersons were assured that the data
obtained would not be linked to specific RECs. After the
interviews were conducted all data was anonymised. The
quantitative component of the study assumed the format
of a descriptive survey of RECs in South Africa that was
based on a structured questionnaire. This method ensured
that each REC was exposed to the same questions so that
their responses could be reliably compared [11]. Develop-
ment of the research tools (questionnaire and interview
guide) was based on the basic functions that are intrinsic
to any research ethics review system [12] as well as known
deficiencies in the system including REC membership,
education and training of REC members, lack of institu-
tional commitment, inadequate initial and continuing
review of protocols, informed consent and review of
research on vulnerable populations.
The questionnaire collected information on membership,
workload, efficiency, review procedures, infrastructure
and resources. It was administered to the administrative
officer of each of 12 RECs in South Africa during 2003.
The questionnaire was completed with the assistance of
the interviewer. This method of face-to-face completion of
structured questionnaires enabled the form to be com-
pleted comprehensively[11]. It also ensured a betterPage 2 of 8
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naires that are usually used in a postal survey. When the
administrative officer was unable to respond to any of the
questions these answers were obtained from the chairper-
son of the REC.
Results
General
Twelve health research ethics committees participated in
the quantitative survey: Nine institutional committees
associated with University Faculties of Health Sciences
that review academic research and industry-sponsored tri-
als, as well as three private committees (Pharmaethics,
South African Medical Association, and Anglogold) that
review primarily industry-sponsored studies. The size of
the 12 committees ranged from seven to 29 members
(median, 16 members), excluding alternate members. Of
the 12 committees, ten had been in operation for at least
ten years, with the oldest established more than 30 years
previously. The remaining two committees were less than
a year old at the time of the survey and both were linked
to historically disadvantaged academic institutions.
Diversity
All of the committees, except one, were comprised of
mostly men (mean proportion men, 63%, range 46%–
82%). Amongst REC members, the representation of
women ranged from 18% to 54%. In 83% of health RECs
surveyed, less than half the members were female. All but
three committees were comprised of mostly white mem-
bers (mean proportion white, 62%, range 10%–86%).
Most of the committees were comprised primarily of
health scientists/clinicians, (56% of all committee mem-
bers) – see table 1. At institutions, the RECs are larger,
hence a variety of scientific disciplines are represented on
the committee. The private RECs are much smaller than
institutional RECs and have very limited scientific review
capacity – one REC had only one scientific/clinical mem-
ber.
Community representatives are defined as people who are
not involved in medical, legal and/or scientific work and
who are preferably from the community [3]. Of the ten
committees reporting a "community representative", the
type of representatives included: priests, a theologian with
a doctoral degree, an ethicist with a doctoral degree, union
members, educators (including a retired headmaster),
local business people, students, a retired nurse, and a Non
Governmental Organisation (NGO) member. While most
of these people were not involved in medical, legal or sci-
entific work, they were not necessarily from the commu-
nities being researched. The RECs could substantiate that
these individuals qualified as community representatives
as they complied with the SAGCP guideline (2000) defi-
nition which states that these representatives should
"preferably" be from the community.
Two of the committees reported that all their members
were independent or not affiliated with the institution,
while another two reported that none of their members
were independent of the institution. The remaining eight
committees reported that less than 50% of their members
were independent or non-affiliated.
Training and development of REC members in research 
ethics
There is a wide differential between the different institu-
tions in terms of training of REC members. While at two
institutions all REC members have received training in
research ethics, at other institutions none of the members
had been trained at the time of the interview. Most of the
training had been attendance of Good Clinical Practice
workshops. Some RECs provide in-house training, time
permitting, at meetings. Others circulate articles on
Research Ethics to members. Funding of RECs is a perpet-
ual problem at most institutions as these bodies receive
low priority within institutions. Many RECs indicated that
funding for training is available as a result of fees charged
for protocol review. This charge is levied only for spon-
sored research. No charge is levied for non-sponsored
investigator driven research. Institutions with the lowest
Table 1: Ethics committee composition in terms of profession
Membership category Category representation on the 12 RECs Percentage of total committee membership in SA
Health scientists/clinicians 12 56%
Nurses 9 6%
Pharmacists 5 5%




Community representatives 10 8%
Statisticians 3 1%Page 3 of 8
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sored research or are charging much less than the other
RECs.
Workload
The average number of protocols reviewed per meeting
varied from four to 30, with a mean of 12. This included
both clinical trials and academic research for all RECs
except one that processes only clinical trials while aca-
demic research is processed by a separate REC altogether.
This is the only institution in South Africa that has three
different RECs, one for clinical trials, one for human
research (academic) and one for animal research.
The median estimated number of protocols reviewed dur-
ing 2002 was 135, with a range from 30 to 360 (the total
number of protocols reviewed during 2002 by the 12
committees was estimated at over 1600). Six RECs had
data for the number of protocols rejected during 2002.
The rejection percentage for these six committees ranged
from 0% to 10% with a mean of 4,52%.
Efficiency of protocol review time
The average time from protocol submission to response
was five weeks, with a range from ten days to ten weeks.
The REC that meets fortnightly is able to process reviews
within the shortest time possible. However, this is a pri-
vate REC and has more fulltime members and members
from the private sector who do not have the same work-
load as academics working at universities. One-third of
the committees (four of twelve) reported no charge for
submissions; of the remaining eight that did charge inves-
tigators submitting a protocol, the average cost was
approximately R2700 ($415) (range, R2000 to R5500/
$308 – $846). This income was essential to the function-
ing of RECs as most institutions typically fund office space
and one administrative assistant post only. All other REC
work is conducted on a voluntary basis by committee
members who derive their income from other disciplines.
Infrastructure and administrative staff
Nine of the 12 committees reported having an office ded-
icated to the committee's activities. One committee
reported having no staff dedicated to the committee's
operations. Of the remaining 11 committees, most (n = 9)
had at least one full-time staff member, with three com-
mittees reporting three full-time staff members.
Discussion
In general, most participating South African health RECs
have been established for at least the last 10 years, are
reviewing a mean of 12 protocols per meeting and are pro-
viding a response to investigators at an average time of 5
weeks. Two important features are highlighted in this
study – firstly, the inadequacy of diversity of REC mem-
bership in SA and secondly, the variability in operations,
infrastructure and training needs amongst the various
RECs.
In 2005, the Department of Health released a national
guideline outlining ethics in health research in South
Africa [1]. Regarding diversity, section 4.1 requires that
RECs must be "representative of the communities they
serve and increasingly reflect the demographic profile of
the population of South Africa; have a minimum mem-
bership of at least nine members, with 60% constituting a
quorum". The committee should "include members of
both gender and not more than 70% of its members must
be men or women". With respect to occupational identity,
there must be "at least two lay persons with no affiliations
with the institution, not currently involved in medical,
scientific or legal work and who are preferably from the
community in which research is to take place; at least one
member with knowledge of and current experience in
areas of research that are regularly considered by the ethics
committee; at least one member with knowledge of, and
current experience in the professional care, counselling or
treatment of people(e.g. medical practitioner, psycholo-
gist, social worker, nurse); and at least one member who
is legally trained. In addition, there should be "at least one
member who has professional training in both qualitative
and quantitative research methodologies".
These guidelines are similar, in principle, to the Interna-
tional Conference of Harmonisation Harmonised Tripar-
tite guideline for Good Clinical Practice (ICH GCP) [13],
except for minimum membership of five in the interna-
tional guideline. In addition, given our history of racial
and gender discrimination, the requirements for diversity,
demographic representation and occupational identity
are specified in more detail in the South African guide-
lines.
This survey indicates that most committees exceed current
minimum membership requirements in terms of num-
bers. However, composition in terms of gender and race
does not meet South African requirements. In most
instances the lack of diversity on RECs is attributed to the
university faculty community – most of whom are white
males. The paucity of Black faculty members at most
health sciences faculties in South Africa is one of the many
consequences of South Africa's history of racial discrimi-
nation and the impact it had on the training of Black med-
ical students [14]. Blacks, in particular those classified as
African under the apartheid system, were restricted entry
into medical schools by a permit system in operation
from 1959 to 1986 [15]. Twelve years after democracy,
while SA has made political progress at a national and
international level, health sciences and health science
research in particular have lagged behind in achievingPage 4 of 8
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within the health sciences profession.
Diversity is an important consideration in SA given the
political history and the asymmetrical power relationship
between researchers (who are predominantly white) and
participants (who tend to be people of colour). Undoubt-
edly, SA is home to many vulnerable groups of poor com-
munities who have limited or no access to education and
health services and who accept authority without ques-
tion [1,3]. Many research participants and research com-
munities meet the definition for vulnerability outlined by
the joint United Nations Program on HIV/AIDS
(UNAIDS) : limited economic development; inadequate
protection of human rights and discrimination on the
basis of health status; inadequate community/cultural
experience with the understanding of scientific research;
limited availability of health care and treatment options
and limited ability of individuals in the community to
provide informed consent [16]. In the past in SA, the
rights of such communities have been violated by health
care providers in positions of authority [17]. These viola-
tions have also occurred in the context of research. The
breast cancer study conducted by Werner Bezwoda, a
white oncology/haematology professor, on black women
at Baragwanath hospital in South Africa in 1995, without
consent or ethics review, placed the health and lives of
these women at considerable risk [18]. The international
precedent for such research ethics violations had been set
by white American researchers in the Tuskegee study in
1932 where poor African-American males were enrolled
into a Syphilis study that was riddled with human rights
violations[19]. As a result, when HIV research escalated
from 1997 onwards and predominantly white researchers
were enrolling predominantly black participants in devel-
oping countries, parallels were drawn with Tuskegee [20].
Empirical research to assess the impact of Tuskegee on
perceptions of African-Americans in relation to research
has demonstrated a negative impact on research to the
extent that distrust of researchers poses a substantial bar-
rier to recruitment for all types of research [21-23]. Histor-
ically, both in SA and in the United States, the conduct of
research by white researchers on people of colour has
been ethically challenging and controversial.
The primary duty of a REC is participant protection. In
addition the South African guideline specifies composi-
tion of such a committee in terms of race, gender and
occupational identity. The OHRP echoes this requirement
in its Code of Federal Regulations (CFR) part 46.107: "The
IRB shall be sufficiently qualified though the experience
and expertise of its members, and the diversity of the
members, including consideration of race, gender and cul-
tural backgrounds and sensitivity to such issues as com-
munity attitudes, to promote respect for its advice and
counsel in safeguarding the rights and welfare of human
subjects"[24]. It may be argued that participant protection
by an REC can occur irrespective of diversity in REC mem-
bership. However, in SA, where the rights of vulnerable
people of colour have been violated in the past by govern-
ment structures composed mainly of white males, partici-
pant protection must be entrusted to a demographically
representative REC in order "to promote respect for its
advice and counsel"[24]. Hence in SA it is important that
protection of the rights of study participants is entrusted
to a representative group of people. The composition of
RECs as predominant white male committees could be
perceived as reinforcing the asymmetrical power relation-
ship that already exists between predominantly white
researchers and predominantly black participants. This
perception needs to be demonstrated in SA with empirical
research.
Diversity in gender distribution is also problematic.
Except for one institution, all Chairpersons of RECs in
South Africa are male. This parallels the gender disparities
that exist in academia with very few women occupying
senior faculty positions. Three RECs have male represen-
tation in excess of the 70% specified by the guideline from
the Department of Health [1,3].
While most committees reflect professional diversity in
membership, there is a dominance of health scientists/cli-
nicians. Amongst the 12 South African RECs surveyed,
doctors, scientists and pharmacists together made up 61%
of the membership. This exceeds international scientific/
clinical membership trends. A survey of 89 IRBs in the
United States in 2001 found that physicians, scientists
and pharmacists together made up 46% of IRB member-
ship [25].
While scientific/clinical membership is high on most
RECs less than half of all RECs have a pharmacologist as a
scientific/clinical member, yet all RECs in South Africa
review both the science and the ethics of protocols. This
represents a serious hiatus as almost all RECs included in
the survey are involved in the review of clinical trials of
investigational drugs. Unlike many other countries in
Africa [4], ethicists are well represented on South African
RECs, in keeping with international trends [25].
Lay representation is present in 80% of RECs but these are
not always people from the community. A distinction
needs to be drawn between lay representation and com-
munity representation. Lay representation on a research
ethics committee usually refers to anyone who has no sci-
entific or medical background. It could therefore include
lawyers, ethicists, priests or theologians. The National
Bioethics Advisory Commission (NBAC, 2001) in the
United States recommends that non-scientists make up atPage 5 of 8
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these "lay" members are in the minority on all RECs and
are not always members of the community being
researched. They have a higher level of education than lay
community members and while they play an important
role in lending a multidisciplinary approach to the review
process, they are not ideally suited to assess the patient
information leaflets from the perspective of a community
member. Community representatives, on the other hand,
would refer to non-professional, non-scientific members
who belong to the community that is being researched.
Generally they would be conversant in the same language
as the research participants and they would share a similar
culture.
In most RECs surveyed in South Africa there is blurring of
these two different categories of representatives. This is
reinforced by the South African research ethics guidelines
which conflate lay representation with community repre-
sentation [1,3]. Often the lay person is taken to be the
lawyer or priest with much higher levels of education than
the average of the community being researched. Often the
priest is someone of the Christian faith with lack of repre-
sentation of other religious sects in the community. The
requirement of the guidelines for lay members to "prefer-
ably" be from communities in which research is con-
ducted does not adequately support the important role
that community members play on a REC [27].
Given the large number of vulnerable populations
involved in health research in SA, efforts to promote com-
munity representation on health RECs and in research
must be encouraged. This can be achieved by ensuring
that REC guidelines on membership distinguish between
lay representation and community representation. By
specifying the proportion of membership that should
account for both categories, for example, 25% lay mem-
bers and 25% community members, balance and objec-
tivity will be added to most RECs especially those that are
predominantly composed of scientists and clinicians affil-
iated to institutions where the proposed research under
review is to be conducted. Specifying that a quarter of the
REC should comprise community members (as opposed
to 1 or 2 members) prevents the intimidation that com-
munity members often experience in an REC that is top
heavy in terms of scientists or clinicians and obviates the
power differentials that would prevent adequate and fair
participation of community members [27]. Finally, edu-
cation of community representatives in research ethics is
to be encouraged as this would empower them to deliber-
ate issues that impact on participant protection in a more
meaningful way.
Most members of institutional health RECs in South
Africa are affiliated to the institution. This parallels trends
internationally [25]. Where the majority of members are
affiliated to the institution, the potential for biased and
inadequate review exists. Members with no affiliation to
the institution are important to lend objectivity to the
review process and protect the REC from facing a conflict
of interest in reviewing research that will benefit the insti-
tution.
As a result of the large proportion of scientific and clinical
members on RECs in South Africa it is inevitable that
some members play dual roles of investigators and REC
members and submit their protocols to their own institu-
tional REC. It is standard practice that the member may
not contribute to the discussion (except for responding to
queries raised during the review) or vote on his/her own
protocol, but is allowed to remain in the meeting room
while the protocol is being discussed. However, this may
place undue pressure on colleagues regarding an objective
and forthright discussion of the submitted protocol. It is
hence important for RECs to implement a policy that
ensures that scientific members who submit their proto-
cols to the RECs that they themselves are members of
leave the meeting room for the full duration of the discus-
sion of their protocol.
While training varied widely amongst RECs, on average
54% of REC members had received training in research
ethics or GCP. Surprisingly, only 20% of members had
research ethics training on 75% of the 89 IRBs in the
United States survey [25]. Definite and urgent training
needs exist at some institutions.
A similar variability was reflected in terms of differences in
workload, review time, infrastructure and training needs
with historically disadvantaged RECs being more affected
than historically advantaged RECs. This is a source of con-
cern as historically disadvantaged RECs could potentially
be further discriminated against in terms of accreditation
criteria established by the NHREC. The health research
ethics guideline released by the Department of Health [1]
defines level 1 and 2 RECs in section 3.3.2. Level one RECs
will be able to review research that poses minimal risk to
human participants. These include health research pro-
posals that that do not involve drug research, biomedical
research involving human tissues, high-budget research
(more than R250 000/$38 461 per annum) and high-
technology research, that is, invasive, radiological, radio-
active and other research requiring substantial equip-
ment. In addition, collaborative international health
research, multi-centre studies, and long-term studies
exceeding one year in duration, are not considered to be
within the competence of a level 1 REC. Level 2 RECs may
review all types of health research. Level 1 RECs are
encouraged, according to the guideline, to develop their
skills to a level 2 REC within a 5 year period. The guidelinePage 6 of 8
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what resources will be made available for training and
development. Given the current situation with RECs in
South Africa it is most likely that some historically disad-
vantaged RECs will only qualify for level one accredita-
tion. While it is important to delineate RECs in terms of
competence in order to maintain the highest standards of
health research in SA, in the absence of redress aimed at
raising the level of functioning of RECs at historically dis-
advantaged institutions, the NHREC system of accredita-
tion will unintentionally serve to perpetuate the injustices
of apartheid.
There are other consequences to the disparity in REC func-
tioning. Most RECs review the research that is conducted
at their own institutions. From the data on workload at
the various RECs, it is evident that historically disadvan-
taged RECs already have very little research activity at their
institutions. This will be reduced even further by an
accreditation system that discriminates against disadvan-
taged institutions. It is established that research is a major
source of funding for institutions and investigators alike.
Hence low levels of research activity at historically disad-
vantaged institutions will impact on the ability of those
institutions to build research funds both at an institu-
tional level and at individual investigator level.
This study has conducted a superficial assessment of oper-
ations of health RECs and a more detailed assessment of
review procedures would provide valuable data. Only the
major RECs that review health research have been
included in this survey. Research on smaller RECs
attached to other training institutions is under way. The
timing of this survey reflects the status quo in 2003 when
the National Health Act and revised national guidelines
were not developed. It will be important to survey the
RECs again in 5–10 years to assess the impact of the new
regulatory and legal mechanisms governing research eth-
ics in SA.
There is enormous potential for future research on RECs
in SA. Clearly training needs of REC members should to
be assessed and addressed in more detail. Funding mech-
anisms for RECs should also be explored to find more sus-
tainable and equitable means of funding RECs.
Community perceptions in respect of demographic repre-
sentation of investigators and RECs is an interesting and
relevant area of further study. Finally, it would be impor-
tant to survey other RECs not primarily involved in health
research.
Conclusion
Most health RECs surveyed are well established given the
context of resource constraints that exist in SA and other
developing countries. However, diversity in terms of race,
gender and occupational identity is suboptimal. Variabil-
ity in operations and training amongst RECs is a reflection
of apartheid entrenched influences in tertiary education in
SA. While legislation now exists to enforce standardiza-
tion of research ethics review systems, no provision has
been made for resources or capacity development, espe-
cially in historically disadvantaged institutions. This has
the potential to perpetuate, if not increase the gap
between highly efficient well resourced RECs and poorly
resourced RECs in South Africa.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
KM conceived of the study, conducted all interviews with
REC chairs and drafted the manuscript. LM conducted the
data analysis and assisted with drafting of the manuscript.
Both authors read and approved the final manuscript.
Acknowledgements
The authors wish to thank all REC chairs who participated in the study – 
Dr Bernard van de Wal, Dr Charles Swanepoel, Dr Danie du Toit, Prof J 
Moodley, Dr Lyn Horn, Prof Gboyega Ogunbanjo, Marzelle Haskins, Prof 
JR Snyman, Prof B Hoek, Dr M Vorster, Prof Christie Renfrew and Prof 
Grace George. We are also appreciative of the contributions made by 
administrative staff at all 12 RECs surveyed. Finally, we would like thank 
Prof Solomon Benatar who as chair of the Interim National REC provided 
us with a list of RECs in SA and Prof Anton Van Niekerk for his supervision 
of the doctoral work that this empirical survey formed a part of.
The study was funded by the first author.
References
1. Department of Health: Ethics in Health Research: Principles, Structures
and Processes. Pretoria 2004.
2. South African Parliament: National Health Act No.61 of 2003 .
3. Department of Health: Guidelines for Good Clinical Practice in the Con-
duct of Clinical Trials in Human Participants in South Africa Pretoria:
DOH; 2000. 
4. Kirigia JM, Wambebe C, Baba-Moussa A: Status of national
research bioethics committees in the WHO African region.
BMC Medical Ethics 2005, 6:10.
5. Cleaton-Jones PE: An Ethical Dilemma: Availability of Antiret-
roviral Therapy after Clinical Trials with HIV Infected
Patients Are Ended.  BMJ 1997, 314:887.
6. Christley HM: Conducting Clinical Trials in South Africa.
Applied Clinical Trials 1998, 9:56-59.
7. CIOMS: International Ethical Guidelines for Biomedical Research Involving
Human Subjects. Geneva 2002.
8. Wilmshurst P: Scientific Imperialism.  BMJ 1997, 314:840.
9. Hyder AA, Wali SA, Khan AN, Teoh NB, Kass NE, Dawson L: Ethi-
cal Review of Health Research: A Perspective from Develop-
ing Country Researchers.  J Med Ethics 2004, 30:68-72.
10. World Medical Association: Declaration of Helsinki:Ethical Prin-
ciples for Medical Research Involving Human Subjects.
Geneva, Switzerland: World Medical Association; 2000. 
11. Bernard HR: Research Methods in Anthropology.  3rd edition.
Walnut Creek: Alta Mira Press; 2002. 
12. Institute of Medicine: Responsible Research Edited by: Hanna KE, Fed-
erman DD, Rodriguez LL. Washington D.C.: The National Academies
Press; 2003. Page 7 of 8
(page number not for citation purposes)
BMC Medical Ethics 2007, 8:1 http://www.biomedcentral.com/1472-6939/8/1Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
13. International Conference on Harmonisation Good Clinical Practice:
Consolidated Guideline.  1997 [http://www.mcclurenet.com/Fed
RegisterPDFs/E6.pdf].
14. Perez G, London L: Forty-Five Years Apart – Confronting the
Legacy of Racial Discrimination at the University of Cape
Town.  SAMJ 2004, 94:764-70.
15. Baldwin-Ragaven L, de Gruchy J, London L: An Ambulance of the Wrong
Colour. Health Professionals, Human Rights and Ethics in South Africa
Cape Town: UCT Press; 1999. 
16. UNAIDS: Ethical Considerations in HIV Preventive Vaccine
Research. UNAIDS Guidance Document.  Geneva 2000.
17. Reid S, Giddy J: Rural health and Human Rights-Summary of a
submission to the Truth and Reconciliation Commission
Health Sector Hearings, 17 June 1997.  S Afr Med J 1998,
88:980-982.
18. Weiss RB: An On-Site Audit of the South African Trial of High
Dose Chemotherapy for Metastatic Breast Cancer and Asso-
ciated Publications.  J of Clin Oncology 2001, 19:2771-2777.
19. Jonsen AR: The Birth of Bioethics New York: Oxford University Press;
1998. 
20. Angell M: The Ethics of Clinical Research in the Third World.
NEJM 1997, 337:847-849.
21. Hamilton LA, Aliyu MH, Lyons PD, May R, Swanson CL, Savage R, Go
RC: African-American community attitudes and perceptions
toward schizophrenia and medical research: an exploratory
study.  J Natl Med Assoc 2006, 98:18-27.
22. Freimuth VS, Quinn SC, Thomas SB, Cole G, Zook E, Duncan T: Afri-
can Americans' views on research and the Tuskegee Syphilis
Study.  Soc Science and Med 2001, 52:797-808.
23. Gamble VN: Under the Shadow of Tuskegee: African Ameri-
cans and Health Care.  Am J of Pub Health 1997, 87:1773-1778.
24. Department of Health and Human Services, National Institutes of
Health, office for Protection from Research Risks: Code of Federal
Regulations, Title 45 part 46.  2001 [http://ohrp.osophs.dhhs.gov/
humansubjects/guidance/45cfr46.htm2004].
25. De Vries RG, Forsberg CP: What Do IRBs Look Like? What
Kind of Support Do They Receive?  Accountability in Research
2002, 9:199-206.
26. National Bioethics Advisory Commission (NBAC): Ethical and Policy
Issues in Research Involving Human Participants. Bethesda 2001.
27. Sengupta S, Lo B: The Roles and Experiences of Non-Affiliated
and Non-Scientific Members of Institutional Review Boards.
Academic Medicine 2003, 78:212-218.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6939/8/1/prepubPage 8 of 8
(page number not for citation purposes)
